Evidence map›Paper›PMID 22529813›Full record

ArticleFrontiers in pharmacology2012

Excitatory GABA: How a Correct Observation May Turn Out to be an Experimental Artifact.

Piotr Bregestovski, Christophe Bernard

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Review
  2. Chemogenetics with PSAMGene therapy · 2025
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Reality of Inhibitory GABA in Neonatal Brain: Time to Rewrite the Textbooks?The Journal of neuroscience : the official journal of the Society for Neuroscience · 2016
    Article
  15. GABA and glycine in the developing brain.The journal of physiological sciences : JPS · 2016
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Depolarizing GABA and developmental epilepsies.CNS neuroscience & therapeutics · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Piotr BregestovskiINSERM URM 1106, Institut de Neuroscience des Systèmes, Aix-Marseille Université Marseille, France.
Christophe Bernard

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The concept of the excitatory action of GABA during early development is based on data obtained mainly in brain slice recordings. However, in vivo measurements as well as observations made in intact hippocampal preparations indicate that GABA is in fact inhibitory in rodents at early neonatal stages. The apparent excitatory action of GABA seems to stem from cellular injury due to the slicing procedure, which leads to accumulation of intracellular Cl(-) in injured neurons. This procedural artifact was shown to be attenuated through various manipulations such as addition of energy substrates more relevant to the in vivo situation. These observations question the very concept of excitatory GABA in immature neuronal networks.

Indexed as

brain slicesenergy substratesGABAgiant depolarizing potentialsin vivo versus in vitro

Identifiers

PMID22529813
PMCPMC3329772

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.